{"news_desk": "Business", "print_page": "5", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By ALEXANDRA STEVENSON and MATTHEW GOLDSTEIN", "person": [{"rank": 1, "role": "reported", "firstname": "Alexandra", "organization": "", "lastname": "STEVENSON"}, {"rank": 2, "role": "reported", "firstname": "Matthew", "organization": "", "lastname": "GOLDSTEIN"}]}, "abstract": "William A Ackman, founder of Pershing Square Capital Management, defends hedge fund's losses in Valeant Pharmaceuticals in conference call with investors; Valeant shares have dropped over 60 percent in past several months due to its drug price hikes.", "type_of_material": "News", "word_count": "1213", "lead_paragraph": "The billionaire, whose firm is among the worst-performing hedge funds this year, used an investor conference call to take a swipe at the media.", "pub_date": "2015-11-10T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Ackman Defends Fund\u2019s Valeant Losses and Digs at \u2018Snide Comments\u2019", "print_headline": "Pershing&#8217;s Founder Defends Valeant Losses and Digs at &#8216;Snide Comments&#8217;"}, "snippet": "The billionaire, whose firm is among the worst-performing hedge funds this year, used an investor conference call to take a swipe at the media.", "multimedia": [{"height": 126, "url": "images/2015/11/10/business/db-hedge-web2/db-hedge-web2-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/11/10/business/db-hedge-web2/db-hedge-web2-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/11/10/business/db-hedge-web2/db-hedge-web2-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/11/10/business/db-hedge-web2/db-hedge-web2-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/11/10/business/db-hedge-web2/db-hedge-web2-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/11/10/business/db-hedge-web2/db-hedge-web2-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/11/10/business/dealbook/ackman-defends-pershings-valeant-losses-and-digs-at-snide-coverage.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Ackman, William A", "name": "persons"}, {"rank": "2", "is_major": "Y", "value": "Valeant Pharmaceuticals International Inc", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Pershing Square Capital Management", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Hedge Funds", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "News and News Media", "name": "subject"}, {"rank": "7", "is_major": "N", "value": "Philidor Rx Services LLC", "name": "organizations"}, {"rank": "8", "is_major": "N", "value": "Pearson, John Michael (1959- )", "name": "persons"}], "blog": [], "_id": "56410adc38f0d80e74ff9725", "source": "The New York Times"}